ライフサイエンスコーパス: age-related hearing loss

1 s benefit significantly reduces with greater age-related hearing loss.

2 Asymptomatic adults 50 years or older with age-related hearing loss.

3 South Carolina Longitudinal Cohort Study of Age-Related Hearing Loss.

4 ng to compromised temporal processing during age-related hearing loss.

5 se aspirin did not affect the progression of age-related hearing loss.

6 shed, as are polygenic risk contributions to age-related hearing loss.

7 ng effort is critical for early diagnosis of age-related hearing loss.

8 aring threshold shifts and the prevention of age-related hearing loss.

9 riving compromised temporal processing under age-related hearing loss.

10 glycoside antibiotic exposure, as well as in age-related hearing loss.

11 ility deteriorates, in a graded manner, with age-related hearing loss.

12 ing in social settings for older adults with age-related hearing loss.

13 ted at speech rates (4 Hz) in listeners with age-related hearing loss.

14 their hearing and usually the first sign of age-related hearing loss.

15 system could be a viable strategy to prevent age-related hearing loss.

16 r leads to neurodegeneration and exacerbates age-related hearing loss.

17 essing of the central auditory system during age-related hearing loss.

18 a well-known correlation between smoking and age-related hearing loss.

19 jury and disease, and a major determinant of age-related hearing loss.

20 psychiatric treatments for older adults with age-related hearing loss.

21 d characterization of a novel mouse model of age-related hearing loss.

22 lowers tHcy levels potentially ameliorating age-related hearing loss.

23 that they play a role in the progression of age-related hearing loss.

24 Eps8 and is a candidate gene for progressive age-related hearing loss.

25 nal changes in IHCs are a potential cause of age-related hearing loss.

26 association between 17 tagSNPs for MSRB3 and age-related hearing loss.

27 orms of deafness, as well as progressive and age-related hearing loss.

28 2 and Skp1 as potential genetic modifiers in age-related hearing loss.

29 as mutations in its gene cause deafness and age-related hearing loss.

30 ion/treatment of inner ear disorders such as age-related hearing loss.

31 s directly contributes to the progression of age-related hearing loss.

32 ure and in analyses excluding those with non-age-related hearing loss.

33 uity has been identified as one component of age-related hearing loss.

34 t environmental exposures may play a role in age-related hearing loss.

35 ying progressive sensorineural hearing loss (age-related hearing loss 5, ahl5) and audiogenic seizure

36 In addition to age-related hearing loss, a substantial number of cases

37 Age-related hearing loss affects how the brain processes

38 Presbycusis, or age-related hearing loss, affects both elderly humans an

39 on to many inbred mouse strains, accelerates age-related hearing loss (AHL) and can worsen auditory p

40 Age-related hearing loss (AHL) in common inbred mouse st

41 Age-related hearing loss (Ahl) is a non-syndromic trait

42 Age-related hearing loss (AHL) is the progressive loss o

43 Inbred mouse strains with age-related hearing loss (AHL) provide valuable models f

44 iety of species and slows the progression of age-related hearing loss (AHL), a common age-related dis

45 of mice vary widely in onset and severity of age-related hearing loss (AHL), an important considerati

46 Age-related hearing loss (AHL), known as presbycusis, is

47 Mutations in cdh23 are associated with age-related hearing loss (AHL).

48 zer (v), modifier-of deaf waddler (mdfw) and Age-related hearing loss (Ahl).

49 mouse strains, A/J, NOD/LtJ and SKH2/J, with age-related hearing loss (AHL).

50 ng the genetic basis of human presbycusis or age-related hearing loss (AHL).

51 e whether deficiencies in Cu/Zn SOD increase age-related hearing loss and cochlear pathology, we coll

52 Age-related hearing loss and noise-induced hearing loss

53 ing an opportunity to study both progressive age-related hearing loss and possible interventional the

54 rtant models for immune response, leukaemia, age-related hearing loss and rheumatoid arthritis.

55 nd noise-induced hearing loss because of its age-related hearing loss and susceptibility to acoustic

56 vironmental, and sex-related determinants of age-related hearing loss and to identify potential inter

57 cluding cardiovascular disease, fatty liver, age-related hearing loss, and breast cancer.

58 ges and suffered a base to apex gradient and age-related hearing loss, and that mutations in cdh23 we

59 Age-related hearing loss (ARHL) (presbycusis) first affe

60 The association between age-related hearing loss (ARHL) and physical or cognitiv

61 Age-related hearing loss (ARHL) has been posited as a po

62 d outer hair cell loss characteristic of the age-related hearing loss (ARHL) in the background strain

63 Age-related hearing loss (ARHL) is a common problem for

64 Age-related hearing loss (ARHL) is a debilitating disord

65 Age-related hearing loss (ARHL) is a major health concer

66 Age-related hearing loss (ARHL) is a prevalent concern i

67 Age-related hearing loss (ARHL) is a threat to future hu

68 Age-related hearing loss (ARHL) is a very heterogeneous

69 ABSTRACT: Age-related hearing loss (ARHL) is associated with chang

70 Age-related hearing loss (ARHL) is associated with chang

71 Age-related hearing loss (ARHL) is associated with the l

72 Presbycusis or age-related hearing loss (ARHL) is the most common senso

73 ric hearing deficits are a common symptom of age-related hearing loss (ARHL), as are specific histopa

74 Presbycusis, or age-related hearing loss (ARHL), is a major public healt

75 lude all those known to be affected in human age-related hearing loss (ARHL), or presbycusis.

76 To research in age-related hearing loss (ARHL), they offer economies of

77 mice of either sex under normal hearing and age-related hearing loss (ARHL).

78 rphological and physiological changes during age-related hearing loss (ARHL).

79 rons that may be relevant for early signs of age-related hearing loss (ARHL).

80 ty of sensorineural etiologies including (1) age-related hearing loss (ARHL); (2) neuropathy related

81 conceptual framework for understanding human age-related hearing loss (ARHL, or presbycusis) holds th

82 occurs at older ages, corresponding with the age-related hearing loss associated with Cdh23ahl.

83 Mice with targeted deletion of Fbxo2 develop age-related hearing loss beginning at 2 months.

84 This adds to the evidence that age-related hearing loss begins as early as the first de

85 protective effects of caloric restriction on age-related hearing loss by promoting the mitochondrial

86 Accelerated age-related hearing loss disrupts high-frequency hearing

87 Age-related hearing loss frequently results in a loss in

88 earing thresholds in these mice demonstrated age-related hearing loss in all homozygous-null, but not

89 ive capacity underlies the high incidence of age-related hearing loss in humans.

90 in a noisy environment, a classic symptom of age-related hearing loss in humans.

91 se SIRT3 was essential for the prevention of age-related hearing loss in mice fed a calorically restr

92 ts an age-noise interaction that exacerbates age-related hearing loss in previously noise-damaged ear

93 this kindred and may serve as one model for age-related hearing loss in the general population.

94 thological evaluation.SIGNIFICANCE STATEMENT Age-related hearing loss is a common neurodegenerative d

95 Age-related hearing loss is a potentially modifiable ris

96 Age-related hearing loss is a progressive hearing loss i

97 Age-related hearing loss is a ubiquitous malady in the g

98 del suggests that the primary factor in true age-related hearing loss is an energy-starved cochlear a

99 Age-related hearing loss is associated with lower hearin

100 A large proportion of age-related hearing loss is caused by loss or damage to

101 Age-related hearing loss is common in an aging populatio

102 Age-related hearing loss is due to death over time, prim

103 The genetic contribution to age-related hearing loss is estimated to be 40%-50%.

104 gets for intervention.SIGNIFICANCE STATEMENT Age-related hearing loss is one of the most common chron

105 Age-related hearing loss is the most prevalent sensory i

106 erved in older adults.SIGNIFICANCE STATEMENT Age-related hearing loss is the most prevalent sensory i

107 Age-related hearing loss is typified by high-frequency t

108 However, the biological basis of age-related hearing loss is unknown.

109 Presbycusis -- age-related hearing loss, is the number one communicatio

110 ty risk factors and studied multiplex family age-related hearing loss (mARHL) and simplex/sporadic ag

111 he objective was to test the hypothesis that age-related hearing loss may be associated with poor vit

112 animal model by comparing noise-induced and age-related hearing loss (NIHL; AHL) in groups of CBA/Ca

113 m response (ABR) which confirmed that severe age-related hearing loss occurred in 8-month-old mice, w

114 hl8 is a key contributor to the early-onset, age-related hearing loss of DBA/2J mice.

115 ion cells, were consistent with the observed age-related hearing loss of these mice beginning with th

116 Age-related hearing loss or presbycusis, the most common

117 Age-related hearing loss, or presbyacusis, is a common d

118 rol subjects and patients with noise- and/or age-related hearing loss (p < 0.05 at all dilutions test

119 ait in the pathophysiological progression of age-related hearing loss, possibly aimed at preserving f

120 ly subjects challenge the common belief that age-related hearing loss (presbyacusis) is based primari

121 Age-related hearing loss (presbycusis) affects one-third

122 Age-related hearing loss (presbycusis) is a chronic heal

123 Age-related hearing loss (presbycusis) is a major health

124 Age-related hearing loss (presbycusis) is a significant

125 e an important factor in the pathogenesis of age-related hearing loss-presbycusis.

126 in a mouse model (of both sexes) of "normal" age-related hearing loss revealed that early pathophysio

127 ed hearing loss (mARHL) and simplex/sporadic age-related hearing loss (sARHL) cases and controls with

128 Age-related hearing loss that impairs daily communicatio

129 ction, the role of these supporting cells in age-related hearing loss, the most common sensory defici

130 cell (OHC) degeneration is a common trait of age-related hearing loss, the objective of this study wa

131 Recent research has linked age-related hearing loss to impaired performance across

132 Age-related hearing loss typically affects the hearing o

133 People suffering from age-related hearing loss typically present with deficits

134 Significant levels of age-related hearing loss were detected in +/Myo7a(sh1-8J

135 er hair cells of the C57BL/6J mouse model of age-related hearing loss, which reveal that cholinergic